The present disclosure relates generally to prosthetic orthopaedic implants, and more particularly, to orthopaedic hip implants.
Many orthopaedic procedures involve the implantation of prosthetic devices to replace badly damaged or diseased joint tissue. Common orthopaedic procedures that involve prosthetic devices include total or partial hip, knee, and shoulder replacements. Hip replacement involves total or partial replacement of the hip ball and socket joint.
A total hip replacement procedure typically involves the implantation of two main component systems: a femoral component and an acetabular component. The femoral component includes a rigid stem that is anchored within the patient's femur and also includes a head that replaces the patient's natural femoral head. The acetabular component is implanted within the acetabulum of the patient and serves as a bearing surface for the head of the femoral component. The acetabular component generally includes an outer shell configured to engage the acetabulum of the patient and an inner bearing or liner coupled to the shell and configured to engage the femoral head. The femoral head and inner liner of the acetabular component form a ball and socket joint that approximates the natural hip joint.
According to an illustrative embodiment, an acetabular hip implant includes an acetabular shell component configured to be implanted within an acetabulum of a patient, a first ring secured to the acetabular shell component, a second ring secured to the first ring, and a third ring secured to the second ring.
The first ring extends around a first longitudinal axis and includes an inner surface and an outer surface. The first ring defines (i) a first closed track extending circumferentially around the first ring and radially through the inner surface and the outer surface of the first ring, and (ii) a second closed track located opposite the first closed track and extending circumferentially around the first ring and radially through the inner surface and the outer surface of the first ring.
The second ring extends around a second longitudinal axis and includes an inner surface and an outer surface. The second ring also includes a first pin extending from the second ring along a first rotational axis into the first closed track, and a second pin extending from the second ring along the first rotational axis into the second closed track. The second ring defines (i) a third closed track extending circumferentially around the second ring and radially through the inner surface and the outer surface of the second ring, and (ii) a fourth closed track extending circumferentially around the second ring and radially through the inner surface and the outer surface of the second ring.
The third ring extends around a third longitudinal axis and includes a third and fourth pin. The third pin extends from the third ring along a second rotational axis into the third closed track and the fourth pin extends from the third ring along the second rotational axis into the fourth closed track. The third ring is secured to a femoral stem component. An inner surface of the third ring is taper locked to the femoral stem component.
The third ring is operable to rotate relative to the second ring about the second rotational axis and the second longitudinal axis. The third ring is prevented from rotating relative to the second ring about any additional axis. The first closed track and the second closed track each extend circumferentially around the first ring a first distance. The third closed track and the fourth closed track each extend circumferentially around the second ring a second distance. In some embodiments, the first distance is a predetermined, patient-specific distance based on a desired range of motion for a patient's hip when the acetabular hip implant is implanted in the acetabulum of the patient. In some embodiments, the second distance is a predetermined, patient-specific distance based on a desired range of motion for a patient's hip when the acetabular hip implant is implanted in the acetabulum of the patient. In some embodiments, the first distance is equal to the second distance.
The acetabular hip implant includes a first pair of sleeves and a second pair a sleeves. The first pair of sleeves is configured to be secured to the first and second pins and sized and shaped to be positioned in the first and second closed tracks. The second pair of sleeves is configured to be secured to the third and fourth pins and sized and shaped to be positioned in the third and fourth closed tracks.
According to a further exemplary embodiment, an acetabular hip implant includes an acetabular shell component configured to be implanted within an acetabulum of a patient, a first ring secured to the acetabular shell component, a second ring secured to the first ring, and a third ring secured to the second ring.
The first ring extends around a first longitudinal axis. The second ring extends around a second longitudinal axis. The second ring is operable to rotate relative to the first ring about the first longitudinal axis and a first rotational axis perpendicular to the first longitudinal axis. The second ring is prevented from rotating relative to the first ring about any additional axis. The third ring extends around a third longitudinal axis. The third ring is operable to rotate relative to the second ring about the second longitudinal axis and a second rotational axis perpendicular to the second longitudinal axis. The third ring is prevented from rotating relative to the second ring about any additional axis. The third ring is secured to a femoral stem component.
The first ring includes an inner surface defining an inner diameter of the first ring and an outer surface opposite the inner surface. The second ring includes an inner surface defining an inner diameter of the second ring and an outer surface defining an outer diameter of the second ring that is less than the inner diameter of the first ring. The third ring includes an inner surface and an outer surface opposite the inner surface. The outer surface of the third ring defines an outer diameter of the third ring that is less than the inner diameter of the second ring.
The first ring defines a first pair of closed tracks extending circumferentially around the first ring a first distance and radially through the inner surface and the outer surface of the first ring. The second ring defines a second pair of closed tracks extending circumferentially around the second ring a second distance and radially through the inner surface and the outer surface of the second ring.
The first distance may be a predetermined, patient-specific distance based on a desired range of motion for a patient's hip when the acetabular hip implant is implanted in the acetabulum of the patient. The second distance may be a predetermined, patient-specific distance based on a desired range of motion for a patient's hip when the acetabular hip implant is implanted in the acetabulum of the patient.
The second ring includes a first pair of pins extending from the outer surface of the second ring along the first rotational axis into the first pair of closed tracks. The third ring includes a second pair of pins extending from the outer surface of the third ring along the second rotational axis into the second pair of closed tracks.
According to a further illustrative embodiment, a method of fabricating a customized patient-specific acetabular hip implant includes (i) determining a desired range of motion for a patient's hip, (ii) selecting a first ring having a first pair of closed tracks defined therein and extending circumferentially around the first ring a first patient-specific distance, (iii) selecting a second ring having a second pair of closed tracks defined therein and extending circumferentially around the second ring a second patient-specific distance, (iv) securing the second ring to the first ring, (v) securing a third ring of the customized, patient-specific acetabular hip implant to the second ring, and (vi) securing the first ring to an acetabular shell component implanted within the acetabulum of the patient.
The first patient-specific distance is based on the desired range of motion for the patient's hip. The second patient-specific distance is based on the desired range of motion for the patient's hip. The method of fabricating a customized, patient-specific acetabular hip implant includes securing a stem component to the third ring of the customized, patient-specific acetabular hip implant.
Other aspects and advantages of the present disclosure will become apparent upon consideration of the following drawings and detailed description, wherein similar structures have similar reference numbers.
The detailed description particularly refers to the following figures, in which:
While the concepts of the present disclosure are susceptible to various modifications and alternative forms, specific exemplary embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the concepts of the present disclosure to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
Terms representing anatomical references, such as anterior, posterior, medial, lateral, superior, inferior, etcetera, may be used throughout this disclosure in reference to both the orthopaedic implants described herein and a patient's natural anatomy. Such terms have well-understood meanings in both the study of anatomy and the field of orthopaedics. Use of such anatomical reference terms in the specification and claims is intended to be consistent with their well-understood meanings unless noted otherwise.
Referring now to
In the exemplary embodiment described herein, the rings 28, 30, 32 are constructed with a biocompatible metal that allows for smooth articulation between opposing surfaces of the respective rings. Examples of such biocompatible metals include stainless steel, cobalt chrome, or titanium, although other metals or alloys may be used. The rings 28, 30, 32 may also be made of any suitable medical-grade polymeric material. Examples of such polymeric materials include polyetheretherketone (PEEK), ultrahigh molecular weight polyethylene (UHMWPE), or acetal.
As seen in
The acetabular shell component 26 may be constructed of any combination of metal, ultra-high molecular weight polyethylene (UHMWPE), ceramic, polyetheretherketone (PEEK), or any other suitable biomedical material. In one exemplary embodiment, the acetabular shell component 26 is constructed of a higher hardness alloy, such as an alloy of cobalt and chromium, for example CoCrMo. The outer ring 28 may be taper-locked, molded, or otherwise secured to the metal shell. The outer surface 34 of the acetabular shell component 26 may include a coating that promotes ingrowth of bone tissue. For example, the outer surface 34 of the metal shell may have a porous structure in the form of a coating of cobalt-chromium alloy beads. The outer surface 34 of the metal shell may also have a coating of an additional or alternative material that promotes bone ingrowth, such as a hydroxyapatite material.
The outer ring 28, as shown in
The closed track 46 is located opposite the closed track 44, as shown in
As shown in
The middle ring 30, as shown in
Similarly to the outer ring 28, the middle ring 30 also includes a pair of elongated slots in the form of closed tracks 64, 66. The closed track 64 extends circumferentially around the middle ring 30 and radially through the inner surface 60 and the outer surface 62 thereof. In a similar manner, the closed track 66 also extends circumferentially around the middle ring 30 and radially through the inner surface 60 and the outer surface 62 of the middle ring 30.
The closed track 64 is located opposite the closed track 66, as shown in
As shown in
As described above, each elongated slot/track 44, 46, 64, 66 is embodied as a closed track. That is, unlike an open track that is open on one or both of its ends, the tracks are 44, 46, 64, 66 are closed on both ends and, as such, do not extend around the full circumference of the ring or open into each other. As such, the closed tracks 44, 46 are discrete from one another, and similarly, the closed tracks 64, 66 are discrete from one another.
As shown in
The middle ring 30, as best seen in
As shown in
When the middle ring 30 is secured to the outer ring 28, the pin 82 (along with its bearing sleeve 88) extends into, and is captured within, the closed track 44. Likewise, the pin 84 (along with its bearing sleeve 90) extends into, and is captured within, the closed track 46. When so assembled, the middle ring 30 is operable to rotate relative to the outer ring 28 about both the rotational axis 86 and the longitudinal axis 38, 58 (as noted above, the axes 38, 58 are collinear when the rings 28, 30 are secured to one another). In the case of rotation of the middle ring 30 relative to the outer ring 28 about the longitudinal axis 38, 58, the middle ring 30 is permitted to move back and forth along an arcuate path defined by the length of the closed tracks 44, 46. Specifically, the middle ring 30 is permitted to rotate relative to the outer ring 28 about the longitudinal axis 38, 58 until the pin 82 (along with its bearing sleeve 88) contacts one end of the closed track 44 at which point the pin 84 (along with its bearing sleeve 90) contacts the opposite end of the closed track 46. Conversely, the middle ring 30 is permitted to rotate relative to the outer ring 28 about the longitudinal axis 38, 58 in the opposite direction until the pin 82 (along with its bearing sleeve 88) contacts the opposite end of the closed track 44 at which point the pin 84 (along with its bearing sleeve 90) contacts the opposite end of the closed track 46. In other words, the length of the closed tracks 44, 46 define the degree/range of rotation permitted by the middle ring 30 relative to the outer ring 28 about the longitudinal axis 38, 58.
It should be appreciated that as the middle ring 30 rotates relative to the outer ring 28 about the longitudinal axis 38, 58, the rotational axis 86 moves in an imaginary plane extending perpendicular to the longitudinal axis 38, 58. As such, in the exemplary embodiment described herein, the rotational axis 86 remains perpendicular to the longitudinal axis 38, 58 throughout movement of the middle ring 30 relative to the outer ring 28. However, it should be appreciated that in other embodiments in which the imaginary line 52 (see
In regard to rotation of the middle ring 30 relative to the outer ring 28 along the rotational axis 86, the configuration of the surfaces of the rings 28, 30 creates a predetermined range/degree of rotation between the two rings. Specifically, the outer surface 62 of the middle ring 30 is configured to abut the inner surface 40 of the outer ring 28 at predetermined locations so as to limit rotation of the middle ring 30 about the rotational axis 86 to a predetermined range/degree of rotation relative to the outer ring 28. As such, the convex curvature of the outer surface 62 of the middle ring 30 facilitates rotation of the middle ring 30 about the rotational axis 86 while maintaining a constant degree of spacing between the outer surface 62 of the middle ring 30 and the inner surface 40 of the outer ring 28. It should be appreciated that the contour and thickness of the middle ring 30 may be a customized, patient-specific surface to produce a desired range of motion for a given patient's hip when the acetabular hip implant 20 is implanted in the acetabulum 22 of the patient. For example, depending on the contour of the outer surface 62 of the middle ring 30, increasing the thickness thereof reduces the predetermined range/degree of rotation of the middle ring 30.
As can be seen in
The inner ring 32, as shown in
The inner ring 32 includes a pair of pins 102, 104 extending radially outward from the outer surface 100 of the inner ring 32. The pins 102, 104 extend away from one another along a second rotational axis 106. In the exemplary embodiment described herein, the body of the inner ring 32 and the pins 102, 104 are embodied as a monolithic metallic component constructed with a biocompatible metal. Alternatively, the body of the inner ring 32 and the pins 102, 104 may be embodied as discrete components secured to one another. In such an embodiment, the body of the inner ring 32 and the pins 102, 104 may be constructed with the same biocompatible metal or polymer or differing biocompatible metals or polymers. Examples of such biocompatible metals and polymers were discussed above.
As shown in
When the inner ring 32 is secured to the middle ring 30, the pin 102 (along with its bearing sleeve 110) extends into, and is captured within, the closed track 64. Likewise, the pin 104 (along with its bearing sleeve 112) extends into, and is captured within, the closed track 66. When so assembled, the inner ring 32 is operable to rotate relative to the middle ring 30 about both the rotational axis 106 and the longitudinal axis 38, 58, 96 (note, as alluded to above, the axes 38, 58, 96 are collinear when the rings 28, 30, 32 are secured to one another). In the case of rotation of the inner ring 32 relative to the middle ring 30 about the longitudinal axis 38, 58, 96, the inner ring 32 is permitted to move back and forth along an arcuate path defined by the length of the closed tracks 64, 66 of the middle ring 30. Specifically, the inner ring 32 is permitted to rotate relative to the middle ring 30 about the longitudinal axis 38, 58, 96 until the pin 102 (along with its bearing sleeve 110) contacts one end of the closed track 64 at which point the pin 104 (along with its bearing sleeve 112) contacts the opposite end of the closed track 66. Conversely, the inner ring 32 is permitted to rotate relative to the middle ring 30 about the longitudinal axis 38, 58, 96 in the opposite direction until the pin 102 (along with its bearing sleeve 110) contacts the opposite end of the closed track 64 at which point the pin 104 (along with its bearing sleeve 112) contacts the opposite end of the closed track 66. In other words, the length of the closed tracks 64, 66 defines the range/degree of rotation permitted by the inner ring 32 relative to the middle ring 30 about the longitudinal axis 38, 58, 96.
It should be appreciated that as the inner ring 32 rotates relative to the middle ring 30 about the longitudinal axis 38, 58, 96, the rotational axis 106 moves in an imaginary plane extending perpendicular to the longitudinal axis 38, 58, 96. As such, in the exemplary embodiment described herein, the rotational axis 106 remains perpendicular to the longitudinal axis 38, 58, 96 throughout movement of the inner ring 32 relative to the middle ring 30. However, it should be appreciated that in other embodiments in which the imaginary line 72 (see
In regard to rotation of the inner ring 32 relative to the middle ring 30 along the rotational axis 106, the configuration of the surfaces of the rings 30, 32 creates a predetermined range/degree of rotation between the two rings. Specifically, the outer surface 100 of the inner ring 32 is configured to abut the inner surface 60 of the middle ring 30 at predetermined locations so as to limit rotation of the inner ring 32 about the rotational axis 106 to a predetermined range/degree of rotation relative to the middle ring 30. As such, the curvature and configuration of the outer surface 100 of the inner ring 32 facilitates rotation of the inner ring 32 about the rotational axis 106 while maintaining a constant degree of spacing between the outer surface 100 of the inner ring 32 and the inner surface 60 of the middle ring 30. It should be appreciated that the contour and thickness of the inner ring 32 may be a customized, patient-specific surface to produce a desired range of motion for a given patient's hip when the acetabular hip implant 20 is implanted in the acetabulum 22 of the patient. For example, depending on the contour of the outer surface 100 of the inner ring 32, increasing the thickness thereof reduces the predetermined range/degree of rotation of the inner ring 32.
The pins 102, 104 (and their associated bearing sleeves 110, 112) are tightly captured within the closed tracks 64, 66. In particular, the pins 102, 104 (and their associated bearing sleeves 110, 112) are sized and shaped to closely correspond to the size and shape of the inner walls 74, 76 of the closed tracks 64, 66 such that the inner ring 32 is prevented from rotating or otherwise moving relative to the middle ring 30 about any additional axis beyond the rotational axis 106 and the longitudinal axis 38, 58, 96.
In use during a surgical procedure, the acetabular shell component 26 is first implanted into the acetabulum 22 of the patient. To do so, a reamer (not shown) may be used to ream or otherwise cut the acetabulum 22 in order to form a hemispherically shaped cavity. The surgeon may then install either the final acetabular shell component or, more commonly, a trial component. Trialing assists the surgeon in final preparation of the acetabulum 22 and in choosing the proper sizes of the various components of the acetabular hip implant 20. After suitable trialing, the trial component is removed and the surgeon may then implant the acetabular shell component 26 into the acetabulum 22. The acetabular shell component 26 may be press fit, screwed, cemented, or otherwise attached to the acetabulum 22.
Thereafter, the outer ring 28 of the assembled ring assembly is taper-locked or otherwise secured to the implanted acetabular shell component 26. Once the ring assembly is secured to the implanted acetabular shell component 26 in such a manner, both the acetabular shell component 26 and the outer ring 28 are stationary relative to one another and hence the acetabulum 22 of the patient. However, both the middle ring 30 and the inner ring 32 are movable relative to the outer ring 28 and the acetabular shell component 26 and hence the acetabulum 22.
The implanted femoral stem 36 is then taper-locked or otherwise locked to the inner ring 32 so as to secure it to the acetabular shell component 26.
Although the rings 28, 30, 32 are herein described as being assembled to one another prior to being secured to the implanted acetabular shell component 26, it should be appreciated that some or all of the rings 28, 30, 32 may be assembled in vivo. Moreover, it should also be appreciated that the rings 28, 30, 32 may be assembled to the acetabular shell component 26 prior to implanting the shell component 26 into the patient's acetabulum 22.
As alluded to above, the acetabular hip implant 20 may be embodied as a customized, patient-specific implant. To do so, the surgeon or other care provider would first determine a desired range of motion for a given patient's hip. After doing so, customized, patient-specific versions of one or more of the rings 28, 30, 32 may be fabricated or selected from a kit of variously configured rings. Customized, patient-specific versions of the rings 28, 30, 32 may be fabricated by, for example, altering the length of a given ring's closed tracks. As described above, the length of the closed tracks defines the range/degree of motion of the relative movement along the longitudinal axis 38, 58, 96 of a given ring relative to another. The angle of the closed tracks may also be varied to create differing directions of rotation. Moreover, the outer and inner surface profiles and/or thicknesses of one or more of the rings may be altered to vary the range/degree of rotation relative to the rotational axis 86 and/or the rotational axis 106.
As such, to assemble a customized, patient-specific version of the acetabular hip implant 20, customized, patient-specific versions of one or more of the rings 28, 30, 32 are assembled based on the desired range of motion for a given patient's hip as preoperatively determined by the surgeon. Thereafter, the rings are secured to an acetabular shell component 26 implanted within the acetabulum 22 of the patient. A stem component may then be secured to the inner ring 32 of the customized, patient-specific acetabular hip implant 20.
As will become apparent from reading the present specification, any of the features of any of the embodiments disclosed herein may be incorporated within any of the other embodiments without departing from the scope of the present disclosure.
While the disclosure has been illustrated and described in detail in the drawings and foregoing description, such an illustration and description is to be considered as exemplary and not restrictive in character, it being understood that only illustrative embodiments have been shown and described and that all changes and modifications that come within the spirit of the disclosure are desired to be protected.
For example, although the outer and middle rings 28, 30 are described herein as having closed tracks and the middle and inner rings 30, 32 are described as having pins, some or all of such elements may be reversed. For example, in some embodiments, the outer and middle rings 28, 30 may have pins extending from the outer surfaces thereof with the middle and inner rings 30, 32 having closed tracks extending radially therethrough.
There are a plurality of advantages of the present disclosure arising from the various features of the apparatus, system, and method described herein. It will be noted that alternative embodiments of the apparatus, system, and method of the present disclosure may not include all of the features described yet still benefit from at least some of the advantages of such features. Those of ordinary skill in the art may readily devise their own implementations of the apparatus, system, and method that incorporate one or more of the features of the present invention and fall within the spirit and scope of the present disclosure.
Number | Name | Date | Kind |
---|---|---|---|
3641590 | Michele | Feb 1972 | A |
3683421 | Martinie | Aug 1972 | A |
3694820 | Scales et al. | Oct 1972 | A |
3708805 | Scales et al. | Jan 1973 | A |
3869730 | Skobel | Mar 1975 | A |
3916451 | Buechel | Nov 1975 | A |
4003095 | Gristina | Jan 1977 | A |
4038704 | Ring | Aug 1977 | A |
4040130 | Laure | Aug 1977 | A |
4040131 | Gristina | Aug 1977 | A |
4229841 | Youm | Oct 1980 | A |
4642123 | Noiles | Feb 1987 | A |
4731088 | Collier | Mar 1988 | A |
4759767 | Lacey | Jul 1988 | A |
4865609 | Roche | Sep 1989 | A |
4911719 | Merle | Mar 1990 | A |
5092898 | Bekki | Mar 1992 | A |
5282865 | Dong | Feb 1994 | A |
5514182 | Shea | May 1996 | A |
5556434 | Epstein | Sep 1996 | A |
5755807 | Anstaett et al. | May 1998 | A |
5800556 | Sanders | Sep 1998 | A |
5888207 | Nieder | Mar 1999 | A |
5888211 | Sanders | Mar 1999 | A |
6002859 | DiGioia, III et al. | Dec 1999 | A |
6042611 | Noiles | Mar 2000 | A |
6168630 | Keller | Jan 2001 | B1 |
6375684 | Kriek | Apr 2002 | B1 |
6629999 | Serafin, Jr. | Oct 2003 | B1 |
6953478 | Bouttens et al. | Oct 2005 | B2 |
7011686 | Ball et al. | Mar 2006 | B2 |
7022140 | Novelli | Apr 2006 | B2 |
7108720 | Hanes | Sep 2006 | B2 |
7309360 | Tornier et al. | Jan 2007 | B2 |
7179298 | Greenlee | Feb 2007 | B2 |
7344565 | Seyer et al. | Mar 2008 | B2 |
7462197 | Tornier et al. | Dec 2008 | B2 |
7465319 | Tornier | Dec 2008 | B2 |
7470287 | Tornier et al. | Dec 2008 | B2 |
7611539 | Bouttens et al. | Nov 2009 | B2 |
7678150 | Tornier et al. | Mar 2010 | B2 |
7854768 | Wiley et al. | Dec 2010 | B2 |
7887544 | Tornier et al. | Feb 2011 | B2 |
8052758 | Winslow | Nov 2011 | B1 |
8075628 | Justin et al. | Dec 2011 | B2 |
8080063 | Ferrand et al. | Dec 2011 | B2 |
8187282 | Tornier et al. | May 2012 | B2 |
8277511 | Tornier et al. | Oct 2012 | B2 |
8287600 | Angibaud | Oct 2012 | B2 |
8303665 | Tornier et al. | Nov 2012 | B2 |
8308810 | Meridew | Nov 2012 | B2 |
8361157 | Bouttens et al. | Jan 2013 | B2 |
8449620 | Hakansson | May 2013 | B2 |
8608805 | Forrer et al. | Dec 2013 | B2 |
8647387 | Winslow | Feb 2014 | B2 |
8690951 | Baum et al. | Apr 2014 | B2 |
8864834 | Boileau et al. | Oct 2014 | B2 |
8870962 | Roche et al. | Oct 2014 | B2 |
8940054 | Wiley et al. | Jan 2015 | B2 |
8974536 | Walch et al. | Mar 2015 | B2 |
9060862 | Castro | Jun 2015 | B2 |
9089435 | Walch et al. | Jul 2015 | B2 |
9132016 | Flaherty et al. | Sep 2015 | B2 |
9233003 | Roche et al. | Jan 2016 | B2 |
9283075 | Wiley et al. | Mar 2016 | B2 |
9408652 | Hassler et al. | Aug 2016 | B2 |
9433507 | Reubelt et al. | Sep 2016 | B2 |
9474619 | Reubelt et al. | Oct 2016 | B2 |
9545312 | Tornier et al. | Jan 2017 | B2 |
9561111 | Goodman | Feb 2017 | B1 |
9925053 | Overes | Mar 2018 | B2 |
10420649 | Overes | Sep 2019 | B2 |
10596005 | Noel | Mar 2020 | B2 |
20030114933 | Bouttens et al. | Jun 2003 | A1 |
20040064190 | Ball et al. | Apr 2004 | A1 |
20040068322 | Ferree | Apr 2004 | A1 |
20040186586 | Seyer et al. | Sep 2004 | A1 |
20040193282 | Hanes | Sep 2004 | A1 |
20040230197 | Tornier et al. | Nov 2004 | A1 |
20050154469 | Novelli | Jul 2005 | A1 |
20050165490 | Tornier | Jul 2005 | A1 |
20050256583 | Bouttens et al. | Nov 2005 | A1 |
20050278030 | Tornier et al. | Dec 2005 | A1 |
20050278032 | Tornier et al. | Dec 2005 | A1 |
20050278033 | Tornier et al. | Dec 2005 | A1 |
20060100713 | Ball | May 2006 | A1 |
20060111788 | Ball | May 2006 | A1 |
20060111789 | Ball | May 2006 | A1 |
20060200248 | Beguin et al. | Sep 2006 | A1 |
20070112430 | Simmen et al. | May 2007 | A1 |
20070173945 | Wiley et al. | Jul 2007 | A1 |
20070225817 | Reubelt et al. | Sep 2007 | A1 |
20070225818 | Reubelt et al. | Sep 2007 | A1 |
20070225821 | Reubelt et al. | Sep 2007 | A1 |
20070250174 | Tornier et al. | Oct 2007 | A1 |
20080183297 | Boileau et al. | Jul 2008 | A1 |
20080228281 | Forrer et al. | Sep 2008 | A1 |
20080294268 | Baum et al. | Nov 2008 | A1 |
20090024221 | Ball | Jan 2009 | A1 |
20090041534 | Bushey | Feb 2009 | A1 |
20090112328 | Tornier et al. | Apr 2009 | A1 |
20090187251 | Justin et al. | Jul 2009 | A1 |
20100023068 | Bouttens et al. | Jan 2010 | A1 |
20100087927 | Roche et al. | Apr 2010 | A1 |
20100222886 | Wiley et al. | Sep 2010 | A1 |
20100256770 | Hakansson | Oct 2010 | A1 |
20110035014 | Forrer | Feb 2011 | A1 |
20110098822 | Walch et al. | Apr 2011 | A1 |
20110166661 | Boileau et al. | Jul 2011 | A1 |
20110166662 | Forrer | Jul 2011 | A2 |
20120004733 | Hodorek | Jan 2012 | A1 |
20120053697 | Palmer | Mar 2012 | A1 |
20120209398 | Richardson | Aug 2012 | A1 |
20120239147 | Winkler | Sep 2012 | A1 |
20130345822 | Grostefon | Dec 2013 | A1 |
20160135958 | Grostefon et al. | May 2016 | A1 |
20160235539 | Overes | Aug 2016 | A1 |
20180116805 | Johannaber | May 2018 | A1 |
20180116808 | Overes | May 2018 | A1 |
20180193156 | Zajac | Jul 2018 | A1 |
20180311045 | Noel | Nov 2018 | A1 |
20190240031 | Kimura | Aug 2019 | A1 |
20190269517 | Palmer | Sep 2019 | A1 |
20200345517 | Morrisey | Nov 2020 | A1 |
Number | Date | Country |
---|---|---|
2003244030 | Apr 2004 | AU |
0664108 | Jul 1995 | EP |
0808617 | Nov 1997 | EP |
0966240 | Oct 2002 | EP |
1844737 | Oct 2007 | EP |
2042129 | Apr 2009 | EP |
2057971 | May 2009 | EP |
1122634 | Sep 1956 | FR |
2357235 | Feb 1978 | FR |
2744627 | Aug 1997 | FR |
2761878 | Oct 1998 | FR |
2899790 | Oct 2007 | FR |
04210353 | Jul 1992 | JP |
05344714 | Dec 1993 | JP |
2011502601 | Jan 2011 | JP |
1005234 | Aug 1998 | NL |
9834567 | Aug 1998 | WO |
0241808 | May 2002 | WO |
2009060006 | May 2009 | WO |
2013148434 | Oct 2013 | WO |
2015051476 | Apr 2015 | WO |
Entry |
---|
PCT International Search Report for International Application No. PCT/IB2020/054625, dated Aug. 12, 2020; 7 pages. |
Number | Date | Country | |
---|---|---|---|
20200405492 A1 | Dec 2020 | US |